CILICANT Launches their third manufacturing facility in India

Active packaging firm, CILICANT, has announced the launch of their third manufacturing facility in Pune. 

Cilicant’s new cGMP compliant facility has up its production capability by three times and backs the company’s end-to-end production and distribution operations to support the increasing demand of pharmaceutical and medical devices during and post-pandemic.

The company’s keen eye for precision is backed by its state-of-the-art manufacturing facility that deploys the latest technology for production, machines that not only deliver the best quality but also have greater production capability.

Cilicant is reputed for its unwavering focus on safety and quality. All products are manufactured in a classified cleanroom. And every employee adheres to meticulous safety standards established in accordance with industry and regulatory best practices.   

By holding DMF with USFDA and Health Canada and ISO 15378:2017, quality assurance is a big part of Cilicant’s operations. 
At its in-house Quality control lab, both raw materials and finished products are tested as per the current US pharmacopeia testing standards and engages high-tech instruments for all its testing. 

CILICANT founder, Mr. Manish Jain commented:
‘Continuous improvement has been the crux of CILICANT’s growth; with our new state-of-the-art manufacturing facility, we intend to serve our customers better than before.’ We thank our customers who have not only supported but encouraged us to outdo ourselves every time, it is due to them we have achieved this endeavor’.

To which CILICANT Sales Director, Mr. Sumeet Sharma added:
The opening of the new manufacturing facility is an important step towards realizing our goals to achieve the current market demand for desiccants. The third manufacturing facility will be the first of many important changes in line with high-quality standards and will suffice the high demand of end-user. This facility is expected to generate sales of desiccants and capture a significant share of the desiccant market for the year 21-22, primarily handle all pharmaceutical clients based in India to suffice the requirement of the regulated market.
Our sales team is absolutely on their toes and very energetic to serve the industry and work closely with clients with the addition of the new facility.

 

Published by CILICANT on Jul 13, 2021